Dickson ER - Search Results

1

Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression.

Van Norstrand MD, Malinchoc M, Lindor KD, Therneau TM, Gershwin ME, Leung PS, Dickson ER, Homburger HA. Van Norstrand MD, et al. Among authors: dickson er. Hepatology. 1997 Jan;25(1):6-11. doi: 10.1002/hep.510250103. Hepatology. 1997. PMID: 8985257

2

Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis.

Neuman M, Angulo P, Malkiewicz I, Jorgensen R, Shear N, Dickson ER, Haber J, Katz G, Lindor K. Neuman M, et al. Among authors: dickson er. J Gastroenterol Hepatol. 2002 Feb;17(2):196-202. doi: 10.1046/j.1440-1746.2002.02672.x. J Gastroenterol Hepatol. 2002. PMID: 11966951 Clinical Trial.

3

Results of long-term ursodiol treatment for patients with primary biliary cirrhosis.

Jorgensen R, Angulo P, Dickson ER, Lindor KD. Jorgensen R, et al. Among authors: dickson er. Am J Gastroenterol. 2002 Oct;97(10):2647-50. doi: 10.1111/j.1572-0241.2002.06043.x. Am J Gastroenterol. 2002. PMID: 12385454 Clinical Trial.

4

Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis.

Lazaridis KN, Juran BD, Boe GM, Slusser JP, de Andrade M, Homburger HA, Ghosh K, Dickson ER, Lindor KD, Petersen GM. Lazaridis KN, et al. Among authors: dickson er. Hepatology. 2007 Sep;46(3):785-92. doi: 10.1002/hep.21749. Hepatology. 2007. PMID: 17680647

5

Deaths on the liver transplant waiting list: an analysis of competing risks.

Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER. Kim WR, et al. Among authors: dickson er. Hepatology. 2006 Feb;43(2):345-51. doi: 10.1002/hep.21025. Hepatology. 2006. PMID: 16440361

6

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.

Angulo P, Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Kamath PS, Dickson ER. Angulo P, et al. Among authors: dickson er. Liver. 1999 Apr;19(2):115-21. doi: 10.1111/j.1478-3231.1999.tb00020.x. Liver. 1999. PMID: 10220741 Clinical Trial.

7

Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis.

Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, Ludwig J. Hashimoto E, et al. Among authors: dickson er. Mayo Clin Proc. 1993 Nov;68(11):1049-55. doi: 10.1016/s0025-6196(12)60897-0. Mayo Clin Proc. 1993. PMID: 8231268

8

The timing of liver transplantation in primary biliary cirrhosis.

Angulo P, Dickson ER. Angulo P, et al. Among authors: dickson er. Baillieres Best Pract Res Clin Gastroenterol. 2000 Aug;14(4):657-68. doi: 10.1053/bega.2000.0110. Baillieres Best Pract Res Clin Gastroenterol. 2000. PMID: 10976021 Review.

9

Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome.

Wiesner RH, Porayko MK, Hay JE, LaRusso NF, Steers JL, Krom RA, Dickson ER. Wiesner RH, et al. Among authors: dickson er. Liver Transpl Surg. 1996 Sep;2(5 Suppl 1):99-108. Liver Transpl Surg. 1996. PMID: 9346709 Free article. Review.

10

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.

Kim WR, Poterucha JJ, Jorgensen RA, Batts KP, Homburger HA, Dickson ER, Krom RA, Wiesner RH, Lindor KD. Kim WR, et al. Among authors: dickson er. Hepatology. 1997 Jul;26(1):22-6. doi: 10.1002/hep.510260103. Hepatology. 1997. PMID: 9214447 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results